Ilaria Grazia Zizzari | Ricerc@Sapienza

Publications

Title	Published on	Year
An ecofriendly iron MOF-based immunosensor for sensitive detection of vascular endothelium growth factor in serum of cancer patients	NANOSCALE	2025
Immunological network signature of naïve non-oncogene-addicted non-small cell lung cancer patients treated with anti-PD1 therapy. A pilot study	CANCERS	2025
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line	JOURNAL OF TRANSLATIONAL MEDICINE	2024
Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2024
Building an in vitro model of sarcopenic obesity	INTERNATIONAL JOURNAL OF BONE FRAGILITY	2024
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients	FRONTIERS IN IMMUNOLOGY	2024
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach	CANCER IMMUNOLOGY, IMMUNOTHERAPY	2023
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity	JOURNAL OF IMMUNOLOGY RESEARCH	2023
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma	www.siica.it	2023
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors	FRONTIERS IN IMMUNOLOGY	2023
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs	JOURNAL OF TRANSLATIONAL MEDICINE	2023
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients	AICC INTERNATIONAL MEETING – TRANSLATIONAL AND PRECISION MEDICINE	2023
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients	CLINICAL CANCER RESEARCH	2022
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study	HUMAN VACCINES & IMMUNOTHERAPEUTICS	2022
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response	EBIOMEDICINE	2022
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential	JOURNAL OF HEPATOLOGY	2022
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: Systematic review and Meta-Analysis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile	BIOMEDICINES	2022

ERC

LS6
LS6_2
LS6_3
LS6_11
LS7_2

Interessi di ricerca

Keywords

anticancer immunotherapy

anti-tumor immune response

biomarkers tumor

dendritic cells

Progetti di Ricerca

NETWORK MEDICINE IN IMMUNO-ONCOLOGY: INTEGRATING CLINICAL AND LABORATORY DATA TO GENERATE PRECISION ROADMAPS FOR CANCER PATIENTS
Impact of circulating immune molecules on clinical outcome of uveal melanoma patients
Prognostic and predictive role of microbioma in NSCLC patients treated with anti-PD1 therapy